Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12667-12675
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12667
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12667
Figure 1 Comparison of prevalence rate of cytomegalovirus infection.
The prevalence rate was significantly higher in the immunocompromised patients than in the immunocompetent patients. CMV: Cytomegalovirus.
Figure 2 Comparison of prevalence rate of cytomegalovirus infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients.
CMV: Cytomegalovirus.
Figure 3 Comparison of prevalence rate of cytomegalovirus infection.
The prevalence rate was significantly higher in ulcerative colitis active patients than in ulcerative colitis inactive patients. CMV: Cytomegalovirus.
Figure 4 Comparison of prevalence rate of cytomegalovirus infection in 4 groups, including, ulcerative colitis inactive patients with immunosuppressive drugs, ulcerative colitis inactive patients without immunosuppressive drugs, ulcerative colitis active patients with immunosuppressive drugs, and ulcerative colitis active patients without immunosuppressive drugs.
CMV: Cytomegalovirus.
Figure 5 Comparison of prevalence rate of Epstein-Barr virus infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients.
EBV: Epstein-Barr virus.
Figure 6 Comparison of prevalence rate of human herpes virus-6 infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients.
HHV6: Human herpes virus-6.
Figure 7 Overlapping prevalence patterns for cytomegalovirus, Epstein-Barr virus, and human herpes virus-6 infection in active ulcerative colitis patients.
CMV: Cytomegalovirus; EBV: Epstein-Barr virus; HHV6: Human herpes virus-6.
Figure 8 Overlapping prevalence patterns for cytomegalovirus, Epstein-Barr virus, and human herpes virus-6 infection in the immunocompromised patients excluding ulcerative colitis.
CMV: Cytomegalovirus; EBV: Epstein-Barr virus; HHV6: Human herpes virus-6.
- Citation: Nahar S, Iraha A, Hokama A, Uehara A, Parrott G, Ohira T, Kaida M, Kinjo T, Kinjo T, Hirata T, Kinjo N, Fujita J. Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis. World J Gastroenterol 2015; 21(44): 12667-12675
- URL: https://www.wjgnet.com/1007-9327/full/v21/i44/12667.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i44.12667